What is the translation of " SOFOSBUVIR " in Chinese?

• sofosbuvir
• 索非布韦
• 索氟布韦

Examples of using Sofosbuvir in English and their translations into Chinese

Sofosbuvir pricing in high-income countries.
索氟布韦在高收入国家的定价.

One tablet contains 400 mg of Sofosbuvir and 100 mg of Velpathaswir.
各片含400mg索非布韦和100mgvelpatasvir。

Sofosbuvir's price has generated debates about sustainability.
索氟布韦的价格已经引发有关可持续性的争论。

Increasing numbers of Chinese have been traveling to India to purchase Sofosbuvir.
越来越多的中国人前往印度购买SoSoxvIR。

Sofosbuvir(PSI-7977) is an HCV RNA replication inhibitor with an EC50 of 92 nM.
Sofosbuvir(PSI-7977)是HCVRNA复制抑制剂，EC50为92nM。

The drug has shown a 100% cure rate in as little as 6 weeks in combination with sofosbuvir.
该药物在与sofosbuvir组合的短短6周内显示出100％的治愈率。

In genotype 2 and 3 HCV infections, sofosbuvir can be used in combination with daclatasvir.
在基因型2和3HCV感染中，sofosbuvir可与达卡他韦联合使用。

Sofosbuvir(SOF), which is easily available in the developing world, is taken as a 400-mg tablet once daily.
Sofosbuvir（SOF）在发展中国家很容易获得，剂量为400mg/天。

The NS5B nucleoside polymerase inhibitor sofosbuvir has the highest barrier to resistance[82].
NS5B核苷聚合酶抑制剂sofosbuvir具有最高的耐药屏障[82]。

Sofosbuvir's registration- approval by each national regulatory authority for each medicine is an inescapable process.
索氟布韦注册--即每个药品在任何国家监管当局批准注册是必经的程序。

Asked Hany Tawfik, 66, a private equity specialist who in 2014 was the first Egyptian to receive sofosbuvir.
岁的HanyTawfik是私人股权专家，他在2014年是第一位接受sofosbuvir的埃及人。

Sofosbuvir is in the nucleotide analog family of medication and works by blocking the hepatitis C NS5B protein.
Sofosbuvir在药物的核苷酸类似物家族中并且通过阻断丙型肝炎NS5B蛋白起作用。

No previous treatments resulted in a sustained virologic response, which made sofosbuvir a highly sought-after drug.
以前的治疗没有导致持续的病毒学应答，这使得sofosbuvir成为一种备受追捧的药物。

The majority of the sofosbuvir dose recovered in urine was GS-331007(78%) while 3.5% was recovered as sofosbuvir.
尿中回收索非布韦剂量多数为GS-331007(78%)而3.5%被回收为索非布韦。

In late 2013, two new HCV therapies were approved by the FDA, simeprevir(Olysio) and sofosbuvir(Sovaldi)1.
这些最新报告在2011年底在FDA批准了两种口服HCV药物：simeprevir（Olysio）和sofosbuvir（Sovaldi）。

The majority of the sofosbuvir dose recovered in urine was GS-331007(78%) while 3.5% was recovered as sofosbuvir.
尿中回收的索非布韦剂量多数是其代谢产物gs-331007（78%）而仅有3.5%依旧为索非布韦。

Results of all clinical trials showed that a treatment regimen containing sofosbuvir was effective in treating multiple types of HCV.
所有临床试验的结果显示，一种包含Sovaldi的治疗方案对多种类型的丙型肝炎病毒有效。

Sofosbuvir is a substrate of drug transporter P-gp and breast cancer resistance protein(BCRP) while GS-331007 is not.
Ledipasvir和sofosbuvir是药物转运蛋白P-gp和BCRP的底物而GS-331007不是。

Hemodialysis can efficiently remove the predominant circulating metabolite of sofosbuvir, GS-331007, with an extraction ratio of 53%.
血液透析可能有效地去除索非布韦的主要循环代谢物，GS-331007，有提取比值53%。

Sofosbuvir(Sovaldi) received FDA approval in 2013, and was the first drug deemed safe and effective without interferon.
Sofosbuvir（Sovaldi）在2013年获得FDA批准，是第一种被认为无干扰素安全有效的药物。

The ASTRAL-3 trial reported an SVR 12 of 95% in genotype 3 patients treated with sofosbuvir+ velpatasvir for 12 weeks[57].
ASTRAL-3临床试验报道，基因3型患者予sofosbuvir+velpatasvir联合治疗12周后，SVR12为95%[57]。

Sofosbuvir is a substrate of drug transporter P-gp and breast cancer resistance protein(BCRP) while GS-331007 is not.
索非布韦是药物转运蛋白P-gp和ag手机客户端苹果版|优惠耐药蛋白(BCRP)的底物而GS-331007不是。

Tell your doctor or dentist that you take Ledipasvir& Sofosbuvir before you receive any medical or dental care, emergency care, or surgery.
告诉你的医生或牙医你接受任何医疗或牙科护理，紧急护理或手术之前服用ledipasvir和sofosbuvir。

Sofosbuvir is a substrate for The p-glycoprotein Transporter drug and the breast cancer resistance protein(BCRP), and GS-331007 is not a substrate.
索非布韦是药物转运蛋白P-gp和乳腺癌耐药蛋白（BCRP）的底物,而gs-331007不是。

Other drugs, such as boceprevir, telaprevir and sofosbuvir, have been shown to improve this cure rate, though all carry additional side effects.
已经证明其他药物，如波普瑞韦，特拉匹韦和sofosbuvir可以提高这种治愈率，尽管这些药物都会带来额外的副作用。

One of the most recent FDA-approved pan-genotype combinations, available under the trade name Epclusa, contains sofosbuvir+ velpatasvir[55].
最近被FDA批准的全基因型复合制剂之一，商品名为Epclusa，包含sofosbuvir+velpatasvir[55]。

Sofosbuvir, daclatasvir and the sofosbuvir/ledipasvir combination are part of the preferred regimens in the WHO guidelines, and can achieve cure rates above 95%.
索非布韦，达卡他韦以及索非布韦/来地帕韦联合治疗都属于世卫组织指南中的首选方案，治愈率可达到95%以上。

We have been able to attain strong market goodwill as a trusted organization engaged in offering our clients Sovihep Sofosbuvir 400 mg Tablets.
我们已经能够获得强大的市场善意，作为一个值得信赖的组织，为我们的客户提供SofihepSofosbuvir400mg片剂。

This study systematically compared the price and affordability of sofosbuvir and ledipasvir/sofosbuvir across 30 countries to assess affordability to health systems and patients.
该研究对比了30个国家的索非布韦和雷迪帕韦的价格和承受能力，评估了健康系统和患者的承受能力。

Gilead has entered into licensing deals with several manufacturers in India to provide generic sofosbuvir to more than 100 low- and middle-income countries.
Gilead公司已进入的几个厂家的许可协议在印度超过100的低收入和中等收入国家提供一般性治疗。